FdaApplication
ANDA 217694
Identifiers
- fda_app_no: ANDA217694
Properties
| Property | Value |
|---|---|
| applicant_name | TWI PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2023-12-05 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TOPIRAMATE | TOPIRAMATE | 15MG | CAPSULE;ORAL |
| TOPIRAMATE | TOPIRAMATE | 25MG | CAPSULE;ORAL |
2 products